176 related articles for article (PubMed ID: 26382576)
1. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
[TBL] [Abstract][Full Text] [Related]
2. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
[TBL] [Abstract][Full Text] [Related]
4. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
[TBL] [Abstract][Full Text] [Related]
5. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
[TBL] [Abstract][Full Text] [Related]
6. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
[TBL] [Abstract][Full Text] [Related]
7. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
[TBL] [Abstract][Full Text] [Related]
8. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
[TBL] [Abstract][Full Text] [Related]
9. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
[TBL] [Abstract][Full Text] [Related]
10. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
11. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
[TBL] [Abstract][Full Text] [Related]
12. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
[TBL] [Abstract][Full Text] [Related]
13. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
[TBL] [Abstract][Full Text] [Related]
15. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
16. Discovery of small molecule human FPR1 receptor antagonists.
Unitt J; Fagura M; Phillips T; King S; Perry M; Morley A; MacDonald C; Weaver R; Christie J; Barber S; Mohammed R; Paul M; Cook A; Baxter A
Bioorg Med Chem Lett; 2011 May; 21(10):2991-7. PubMed ID: 21486695
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of tryptophan containing dipeptide derivatives as formyl peptide receptor 1 antagonist.
Hwang TL; Hung CH; Hsu CY; Huang YT; Tsai YC; Hsieh PW
Org Biomol Chem; 2013 Jun; 11(22):3742-55. PubMed ID: 23629449
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
19. Intravital Imaging of Neutrophil Recruitment Reveals the Efficacy of FPR1 Blockade in Hepatic Ischemia-Reperfusion Injury.
Honda M; Takeichi T; Hashimoto S; Yoshii D; Isono K; Hayashida S; Ohya Y; Yamamoto H; Sugawara Y; Inomata Y
J Immunol; 2017 Feb; 198(4):1718-1728. PubMed ID: 28062700
[TBL] [Abstract][Full Text] [Related]
20. The peptidomimetic Lau-(Lys-βNSpe)
Skovbakke SL; Winther M; Gabl M; Holdfeldt A; Linden S; Wang JM; Dahlgren C; Franzyk H; Forsman H
Biochem Pharmacol; 2016 Nov; 119():56-65. PubMed ID: 27614010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
